SARASIN & PARTNERS LLP – Edwards Lifesciences Corporation Transaction History
SARASIN & PARTNERS LLP portfolio value:
$20.91M
portfolio value
SARASIN & PARTNERS LLP quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.18% | -456 shares | -3.19M | $82.63 | 253.07K |
Q2 2022 | share | Increase | 0.00% | 253.53K shares | 24.10M | $95.09 | 253.53K |
Q1 2022 | share | Decrease | -100.00% | -254.53K shares | -32.97M | $117.72 | 0 |
Q4 2021 | share | 0.00% | 0 shares | 4.15M | $130.68 | 254.53K | |
Q3 2021 | share | 0.00% | 0 shares | 2.45M | $113.21 | 254.53K | |
Q2 2021 | share | Increase | +25.91% | 52.38K shares | 9.45M | $103.57 | 254.53K |
Q1 2021 | share | 0.00% | 0 shares | -1.53M | $83.64 | 202.14K | |
Q4 2020 | share | Increase | +23.66% | 38.67K shares | 5.39M | $91.23 | 202.14K |
Q3 2020 | share | Increase | +23.84% | 31.47K shares | 3.92M | $79.82 | 163.47K |
Q2 2020 | share | Increase | 0.00% | 132K shares | 9.12M | $69.11 | 132K |
Q1 2020 | share | Decrease | -100.00% | -95.76K shares | -7.44M | $62.87 | 0 |
Q4 2019 | share | Decrease | -0.27% | -261 shares | 408K | $77.76 | 95.76K |
Q3 2019 | share | Increase | +46.33% | 30.40K shares | 2.99M | $73.3 | 96.03K |
Q2 2019 | share | Decrease | -1.15% | -765 shares | -193K | $61.58 | 65.62K |
Q1 2019 | share | 0.00% | 0 shares | 844K | $63.78 | 66.39K | |
Q4 2018 | share | 0.00% | 0 shares | -463K | $51.06 | 66.39K | |
Q3 2018 | share | Increase | 0.00% | 66.39K shares | 3.85M | $58.03 | 66.39K |